Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q3)Feb 28, 2026 | (Q2)Nov 30, 2025 | (Q1)Aug 31, 2025 | (FY)May 31, 2025 | (Q4)May 31, 2025 | (Q3)Feb 28, 2025 | (Q2)Nov 30, 2024 | (Q1)Aug 31, 2024 | (FY)May 31, 2024 | (Q4)May 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -182.32%-198.99K | -269.48%-489.53K | -94.28%-296.64K | -139.78%-236.54K | -38.32%-259.9K | 860.36%241.71K | -306.48%-132.49K | -122.56%-152.68K | 681.43%594.62K | -61.67%-187.9K |
| Net income from continuing operations | 19.96%-599.97K | 75.95%1.73M | 63.68%-73.4K | -3.12%-3.21M | -354.39%-3.25M | 18.33%-749.59K | 319.79%982.97K | 80.52%-202.09K | 37.10%-3.12M | -186.37%-714.21K |
| Operating gains losses | -57.44%70.04K | 32.28%-129.15K | 450.02%67.37K | 236.38%281.65K | 587.73%342.73K | -9.72%164.58K | -436.56%-190.71K | 102.47%12.25K | 42.81%-206.52K | 124.91%49.84K |
| Asset impairment expenditure | ---- | ---- | ---- | --433.08K | ---- | ---- | ---- | ---- | --0 | --0 |
| Unrealized gains and losses of investment securities | -178.65%-342.83K | -93.41%-1.81M | -761.12%-316.39K | -18.17%1.93M | 7,881.95%2.39M | -37.65%435.87K | -425.19%-936.93K | -96.44%47.86K | -51.55%2.36M | 111.44%29.88K |
| Remuneration paid in stock | --527.79K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Deferred tax | ---- | ---- | ---- | -251.80%-191.78K | ---- | ---- | ---- | ---- | 113.40%126.34K | 118.11%126.34K |
| Other non cashItems | -57.80%88.64K | -345.47%-234.84K | 114.64%16.2K | -83.88%233.9K | -115.83%-75.2K | 201.70%210.05K | 225.81%95.67K | -110.24%-110.64K | 12.11%1.45M | -20.79%475.14K |
| Change In working capital | -68.29%57.33K | 48.56%-42.95K | -90.42%9.57K | 1,511.79%288.73K | 159.05%91.46K | -14.38%180.8K | -160.83%-83.48K | 146.71%99.94K | 95.57%-20.45K | 64.16%-154.88K |
| -Change in receivables | -1,945.96%-26.71K | 49.19%-10.63K | 98.53%-221 | 50.30%-35.05K | 97.95%-507 | -97.83%1.45K | -147.43%-20.91K | 85.51%-15.08K | -553.87%-70.52K | -113.41%-24.71K |
| -Change in payables and accrued expense | -53.14%84.04K | 48.34%-32.32K | -91.48%9.8K | 30.24%476.41K | 31.83%244.61K | 24.14%179.36K | -142.95%-62.57K | 204.64%115.02K | 67.61%365.79K | 134.06%185.55K |
| -Change in other current assets | ---- | ---- | ---- | 51.65%-152.64K | ---- | ---- | ---- | ---- | 54.62%-315.72K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -182.32%-198.99K | -269.48%-489.53K | -94.28%-296.64K | -139.78%-236.54K | -38.32%-259.9K | 860.36%241.71K | -306.48%-132.49K | -122.56%-152.68K | 681.43%594.62K | -61.67%-187.9K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -345.15%-474.95K | -2,307.66%-456.64K | -2,627.72%-106.7K | 86.16%-18.97K | ||||||
| Net PPE purchase and sale | --0 | --0 | ---- | ---- | ---- | -176.78%-61.13K | 96.38%-802 | ---- | ---- | ---- |
| Net business purchase and sale | 76.40%-10.75K | 32.98%-5.65K | ---- | ---- | ---- | ---45.57K | ---8.42K | ---- | ---- | ---- |
| Net investment purchase and sale | --0 | ---450.99K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net other investing changes | ---464.19K | ---- | ---- | ---- | ---- | ---- | 91.53%-9.74K | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -345.15%-474.95K | -2,307.66%-456.64K | ---- | ---- | ---- | -2,627.72%-106.7K | 86.16%-18.97K | ---- | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 384.84%453.09K | 44.36%246.25K | 782.39%1.31M | 129.86%180.26K | 113.89%20.46K | -241.94%-159.07K | 531.74%170.58K | 128.03%148.29K | -44.73%-603.73K | 52.47%-147.28K |
| Net issuance payments of debt | --454.59K | -3.16%252.35K | 55.92%322.73K | 282.07%499.02K | 144.55%31.46K | --0 | 1,121.30%260.58K | 146.66%206.98K | -120.20%-274.08K | -310.40%-70.62K |
| Net common stock issuance | ---1.5K | ---6.1K | --1.09M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net other financing activities | ---- | ---- | -69.07%-99.23K | 3.31%-318.75K | 85.65%-11K | -49.01%-159.07K | -47.92%-90K | 31.28%-58.69K | -12.64%-329.65K | ---76.66K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 384.84%453.09K | 44.36%246.25K | 782.39%1.31M | 129.86%180.26K | 113.89%20.46K | -241.94%-159.07K | 531.74%170.58K | 128.03%148.29K | -44.73%-603.73K | 52.47%-147.28K |
| Net cash flow | ||||||||||
| Beginning cash position | 1,038.45%315.68K | 7,215.40%1.02M | -74.85%5.39K | -68.01%21.45K | -86.10%24.46K | -62.66%27.73K | -94.48%13.88K | -68.01%21.45K | -87.89%67.05K | 1.16%175.93K |
| Current changes in cash | -818.33%-220.85K | -3,761.03%-699.92K | 23,133.60%1.01M | -517.40%-56.28K | 65.24%-44.85K | -128.46%-24.05K | 117.00%19.12K | -102.97%-4.39K | 98.24%-9.12K | -5.30%-129.04K |
| Effect of exchange rate changes | -121.03%-4.37K | -438.49%-28.39K | 47.55%-1.66K | 210.27%40.23K | 201.29%25.78K | 21.05%20.78K | 91.88%-5.27K | -108.63%-3.17K | -211.50%-36.48K | -262.39%-25.45K |
| End cash Position | 269.83%90.46K | 936.07%287.29K | 7,215.40%1.02M | -74.85%5.39K | -74.85%5.39K | -86.10%24.46K | -62.66%27.73K | -94.48%13.88K | -68.01%21.45K | -68.01%21.45K |
| Free cash from | -210.19%-198.99K | -267.25%-489.53K | -94.28%-296.64K | -139.78%-236.54K | -12,198.83%-145.07K | 243.92%180.59K | -417.13%-133.29K | -122.56%-152.68K | 681.43%594.62K | -99.36%1.2K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.